Clinical features and prognostic biomarkers in patients with SMARCA4-mutated non-small cell lung cancer
<i>SMARCA4</i>-Mut is an adverse prognostic feature in NSCLC patients. Napsin A expression in <i>SMARCA4</i>-Mut patients is associated with prolonged OS.
Authors
- Jacek Jassem (ORCID: https://orcid.org/0000-0002-8875-6747)
- Lijuan Qu (ORCID: https://orcid.org/0000-0002-0511-1362)
- Yuxin Guo (ORCID: https://orcid.org/0000-0003-4138-5106)
- Qinghong Liu
- Xiandong Lin (ORCID: https://orcid.org/0000-0002-3250-4014)
- Jinyu Long (ORCID: https://orcid.org/0009-0000-5547-456X)
- Yingfang Song
- Peter Ping Lin (ORCID: https://orcid.org/0000-0002-6869-9490)
- Masatsugu Hamaji (ORCID: https://orcid.org/0000-0002-9808-8260)
- Zongyang Yu
- Hiroyuki Adachi (ORCID: https://orcid.org/0000-0002-8928-9394)
- Jinhe Xu (ORCID: https://orcid.org/0000-0003-2681-9893)
- Chenxi Wang (ORCID: https://orcid.org/0000-0002-0174-0911)
- Xingguang Luο (ORCID: https://orcid.org/0000-0003-3585-042X)
- Ying Chen (ORCID: https://orcid.org/0000-0003-4990-8952)
- Jun Lu (ORCID: https://orcid.org/0000-0003-0363-7288)
- Chengzhi Zhou (ORCID: https://orcid.org/0000-0002-1758-0035)
- Zhengbo Song
- Ruiying Rao
Institutions
- Fujian Medical University (CN)
- Yale University (US)
- First Affiliated Hospital of Guangzhou Medical University (CN)
- Zhejiang Cancer Hospital (CN)
- State Key Laboratory of Respiratory Disease (CN)
- Nara Medical University (JP)
- Gdańsk Medical University (PL)
- Yokohama City University (JP)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- Translational Lung Cancer Research
- Published
- 2024-08-01
- DOI
- https://doi.org/10.21037/tlcr-24-381
- Citations
- 2
- Primary Topic
- Chromatin Remodeling and Cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.47
Funders
- Fujian Medical University